New MIMS table helps prescribers choose asthma inhalers

Prescribers can now turn to a handy MIMS comparison table for help deciding on suitable combination inhalers for their asthma patients.

Prescribers have an increasing number of asthma inhalers to choose from. | VOISIN/PHANIE/SCIENCE PHOTO LIBRARY
Prescribers have an increasing number of asthma inhalers to choose from. | VOISIN/PHANIE/SCIENCE PHOTO LIBRARY

With the ever-increasing range of LABA/corticosteroid asthma combination inhalers, including three devices launched just this year, the new MIMS table allows a quick comparison of all the possible options.

The table provides essential information for healthcare professionals prescribing a LABA/corticosteroid combination device for the first time, either when stepping up treatment in patients not adequately controlled on an inhaled corticosteroid and a short-acting β2 agonist, or when starting a combination inhaler in patients already adequately controlled on a LABA and a corticosteroid taken separately.

It is also designed to help prescribers looking for an alternative LABA/corticosteroid device where the existing choice is unsuitable.

The table summarises the following key information:

  • Metered/pre-dispensed and delivered doses
  • Inhaler type (breath-actuated or pressurised metered-dose)
  • Dose counter and confirmation features
  • Compatible spacers
  • Age range for use
  • Suitability for combined maintenance and reliever therapy.

All currently available LABA/corticosteroid inhalers are included, and the table will be updated as further products become available.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in